CVE Tools

CVE-2026-12646

No known exploitation. EPSS puts it in the 68th percentile. A vendor fix is available.

Published Updated Sources: CVE.org, NVD

What to do

The vendor has published a fix. Version details are below where the sources state them.

Steps

Written by AI from the record
  1. Check your Ivanti Neurons for ITSM version and confirm whether it is earlier than 2026.2.
  2. If you are on a version before 2026.2, schedule an immediate upgrade to Ivanti Neurons for ITSM 2026.2.
  3. If you cannot upgrade right away, restrict who can log into Neurons for ITSM (reduce active user accounts and revoke unnecessary access) and limit network access to only trusted admin networks.
  4. After upgrading, verify the update completed successfully and that the Neurons for ITSM web/API endpoints now run the 2026.2 version.

What it is

From the CVE record

A Missing Authorization vulnerability in Ivanti Neurons for ITSM before 2026.2 allows a remote authenticated attacker to execute arbitrary code on the server.

In plain language

Written by AI from the record

CVE-2026-12646 is a serious authorization flaw in Ivanti Neurons for ITSM that lets a logged-in user run commands as the server; small businesses using this software should upgrade to 2026.2 urgently.

CVE-2026-12646 is a Missing Authorization flaw in Ivanti Neurons for ITSM (pre-2026.2) that allows a remote authenticated attacker with low-privilege access to execute arbitrary code on the server without sufficient permission checks.

If you're affected

  • Server takeover
  • Widespread internal access
  • Service disruption
  • Operational downtime

Exploitation

Where each signal puts this CVE on the scale from published to confirmed exploited.

EPSS68th
CISA KEV

Not in the catalog. CISA has not confirmed exploitation.

Public exploits

No public exploit or proof of concept found in the sources we track.

EPSS

1.2% chance of exploitation activity in the next 30 days, which ranks it in the 68th percentile of scored CVEs.

Exploit Prediction Scoring System, FIRST.org. A probability, not a confirmation.

Lifecycle

9 events over 10 days, from the signal feeds we watch.

  1. Patch availablerecord updated
  2. OpenVAS check added
  3. Record updated
  4. Publishedweakness classified, att&ck mapped, record updated, record updated

Affected products

Technical detail

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H

Scored 9.9 by NVD.

How it is reached

  • Attack Vector NetworkExploitable remotely over the network without any special conditions
  • Attack Complexity LowNo special conditions — the attack can be reliably reproduced
  • Privileges Required LowRequires basic user-level privileges
  • User Interaction NoneNo user interaction needed — fully automated exploitation

Scope

  • Scope ChangedThe exploit can affect other components (e.g. sandbox escape, host compromise from VM)

Impact if exploited

  • Confidentiality HighTotal information disclosure — all data in the component is compromised
  • Integrity HighTotal loss of integrity — attacker can modify any data in the component
  • Availability HighTotal denial of service — the component is completely unavailable

Weaknesses

ATT&CK techniques

Mapped from the weaknesses above (CWE to ATT&CK), not observed in attacks.

Sources

Watch the software you run.

My Stack ranks new CVEs for your products by real-world exploitation, so the next serious one reaches you without reading every advisory.

We'll flag the next CVE, public exploit or patch for Ivanti Neurons For ITSM, not every advisory.

We use analytics cookies to see which pages and articles actually help people. Decline and none of them run — the site works the same. What we store